Publications for IWQOL-Lite (and its predecessor IWQOL)

Bibliographic references of the original questionnaire

Kolotkin R.L., Head S., Hamilton M.A., Tse C.T.J. Assessing impact of weight on quality of life. Obesity Research. 1995; 3: 49-56.

Kolotkin R.L., Head S., Brookhart A. Construct validity of the Impact of Weight on Quality of Life questionnaire. Obesity Research. 1997; 5: 434-441.

Kolotkin R.L., Crosby R.D., Kosloski K.D., Williams G.R. Development of a brief measure to assess quality of life in obesity. Obesity Research. 2001; 9: 102-111.

Kolotkin R.L., Crosby R.D. Psychometric evaluation of the Impact Of Weight On Quality Of Life-Lite Questionnaire (IWQOL-Lite) in a community sample. Quality of Life Research. 2002; 11: 157-171.

Other IWQOL-Lite publications

Steffen K.J., King W.C., White G.E., Subak L.L., Mitchell J.E., Courcoulas A.P., Flum D. R., Strain G., Sarwer D. B., Kolotkin R.L., Pories W., Huang A. Sexual functioning of men and women with severe obesity prior to bariatric surgery. Surgery for Obesity and Related Diseases, in press.

Allet L., Müller-Pinget S., Punt I., Edelstend C., Ballif A., Golayc A., Pataky Z. Dance therapy combined with patient education improves quality of life of persons with obesity: A pilot feasibility study for a randomised controlled trial. Obesity Research & Clinical Practice, in press.

Ghroubi S., Kossemtini W., Mahersi S., Elleuch W., Chaabene M., Habib Elleuch M. Contribution of isokinetic muscle strengthening in the rehabilitation of obese subjects. Annals of Physical and Rehabilitation Medicine, in press.

Weil R., Kovacs B., Miller N., McDermott M.P., Wall M., Kupersmith M, Pi-Sunyer F.X., and the NORDIC Idiopathic Intracranial Hypertension Study Group. A 6-Month Telephone-Based Weight Loss Intervention in Overweight and Obese Subjects with Idiopathic Intracranial Hypertension. Obesity Science and Practice, in press.

Reaney M., Elash C.A., Litcher-Kelly L. Patient Reported Outcomes (PROs) used in recent phase 3 trials for Type 2 diabetes: a review of concepts assessed by these PROs and factors to consider when choosing a PRO for future trials. Diabetes Research and Clinical Practice, in press.

Chacko S.A., Yeh G.H., Davis R.B., Wee C.C. A mindfulness-based intervention to control weight after bariatric surgery: Preliminary results from a randomized controlled pilot trial. Complementary Therapies in Medicine, October 2016; Volume 28, Pages 13-21. http://dx.doi.org/10.1016/j.ctim.2016.07.001.

Fujioka K., O'Neil P.M., Davies M., Greenway F., Lau D.C.W., Claudius B., Vang Skjøth T., Jensen C.B., Wilding J.P.H. Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers. Obesity, 2016; 24, 2278-2288. doi:10.1002/oby.21629http://www.tandfonline.com/doi/abs/10.1080/03007995.2016.1251892.

Bays H., Pi-Sunyer X., Uddén Hemmingsson J., Claudius B., Jensen C.B., Van Gaal L. Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects. Current Medical Research and Opinion, 2016; http://dx.doi.org/10.1080/03007995.2016.1251892.

Carbajo M.A., Luque-de-León E., Jiménez J.M. et al. Laparoscopic One-Anastomosis Gastric Bypass: Technique, Results, and Long-Term Follow-Up in 1200 Patients. Obesity Surgery, 2016; doi:10.1007/s11695-016-2428-1.

Sturgiss E. A., Sargent G. M., Haesler E., Rieger E. and Douglas K. Therapeutic alliance and obesity management in primary care — a cross-sectional pilot using the Working Alliance Inventory. Clinical Obessity, 2016; doi:10.1111/cob.12167.

Raaijmakers L.C.H., Pouwels S., Thomassen S.E.M., Nienhuijs S.W. Quality of life and bariatric surgery: a systematic review of short- and long-term results and comparison with community norms. European Journal of Clinical Nutrition, 2016.

Twells L.K., Gregory D.M., Midodzi W.K., Dillon C., Kovacs C.S., MacDonald D., et al. The Newfoundland and Labrador Bariatric Surgery Cohort Study: Rational and Study Protocol. BMC Health Services Research, 2016; 16(1):618.

Hübner C., Schmidt R., Selle J., Köhler H., Müller A., et al. Comparing Self-Report Measures of Internalized Weight Stigma: The Weight Self-Stigma Questionnaire versus the Weight Bias Internalization Scale. 2016; PLOS ONE 11(10): e0165566. doi: 10.1371/journal.pone.0165566.

Saunders K.H., Igel L.I., Aronne L.J. An update on naltrexone/bupropion extended-release in the treatment of obesity. Drug Evaluation, 2016; 2235-2242. http://dx.doi.org/10.1080/14656566.2016.1244527.

Strain G.W., Torghabeh M.H., Gagner M. et al. The Impact of Biliopancreatic Diversion with Duodenal Switch (BPD/DS) Over 9 Years. Obesity Surgery, 2016; doi:10.1007/s11695-016-2371-1.

Croghan I.T., Ebbert J.O., Schroeder D.R., Hurt R.T., Hagstrom V., Clark M.M. A randomized, open-label pilot of the combination of low-level laser therapy and lorcaserin for weight loss. BMC Obesity, 2016; doi:10.1186/s40608-016-0122-4.

Coffin B., Maunoury V., Pattou F. et al. Impact of intragastric balloon before laparoscopic gastric bypass on patients with super obesity: a randomized multicenter study. Obesity Surgery, 2016; doi:10.1007/s11695-016-2383-x.

Truong E.A.K., Olson K.L., Emery C.F. Repressive coping, stigmatization, psychological distress, and quality of life among behavioral weight management participants. Eating Behaviors, 2016; 206-210. http://dx.doi.org/10.1016/j.eatbeh.2016.06.007

Pointer S.D., Rickstrew J., Slaughter J.C., Vaezi M.F. and Silver H.J. Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women. Alimentary Pharmacology and Therapeutics, 2016; doi:10.1111/apt.13784.

Kaur M., Singh S. Effect of obesity on quality of life in middle aged females. International Journal of Physiotherapy, August 2016; Vol 3(4), 435-438.

Kushner R.F., Choi S.W., Burns J.L. Development of a six-factor questionnaire for use in weight management counseling. Patient Education and Counseling; 2016, in press.

Amichaud R1., Donatini G., Barussaud M.L., Charalambous C., Ingrand I., Faure J.P. Health-related quality of life after laparoscopic sleeve gastrectomy. A multicentric experience. Minerva Chirurgica, 2016 Aug; 71(4): 245-51.

Panosian J., Ding S.A., Wewalka M., Simonson D.C., Goebel-Fabbri A., Foster K., Halperin F., Vernon A., Goldfine A.B. Physical Activity in Obese Type 2 Diabetes Following Gastric Bypass or Medical Management. The American Journal of Medicine, 2016; doi:10.1016/ j.amjmed.2016.07.019.

Apovian C.M., Shah S.N., Wolfe B.M. et al. Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial. Obesity Surgery, 2016; doi:10.1007/s11695-016-2325-7.

Kalarchian M. A., Marcus M. D., Courcoulas A. P., Lutz C., Cheng Y., and Sweeny G. Structured dietary intervention to facilitate weight loss after bariatric surgery: A randomized, controlled pilot study. Obesity, 2016; doi:10.1002/oby.21591.

Kolotkin R.L., Fujioka K., Wolden M.L., Brett J., Bjørner J.B. Improvements in health-related quality of life with liraglutide compared with placebo in weight management. Clinical Obesity, 2016; 6: 233-242.

Malhotra N., Kulhara P., Chakrabarti S., Grover S. Lifestyle related factors & impact of metabolic syndrome on quality of life, level of functioning & self-esteem in patients with bipolar disorder & schizophrenia. Indian Journal of Medical Research, 2016; 143, 434-442.

Melasch J.T., Rullmann M., Hilbert A., Luthardt J., Becker G.A., Patt M., Stumvoll M., Blüher M., Villringer A., Arelin K., Meyer P.M., Bresch A., Sabri O., Hesse S., Pleger B. Sex differences in serotonin-hypothalamic connections underpin a diminished sense of emotional well-being with increasing body weight. International Journal of Obesity (Lond), 2016.

Kolotkin R.L., Gadde K.M., Peterson C.A., Crosby R.D. Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: what mediates improvement? Quality of Life Research, 2016; 25 (5): 1237-1244.

Kroes M., Osei-Assibey G., Baker-Searle R., Huang J. Impact of weight change on quality of life in adults with overweight/obesity in the United States: a systematic review. Current Medical Research & Opinion, 2016; 32: 485-508.

Ghazala D.M., and Farhood H.F. Impact of Weight on Quality of Life in Obese Adults. Journal of Babylon University/Pure and Applied Sciences, 2016; 24: 501-520.

Hattar A., Pal S., Hagger M.S. Predicting Physical Activity-Related Outcomes in Overweight and Obese Adults: A Health Action Process Approach. Applied Psychology Health and Well-Being, 2016; 8: 127-151.

Befort C.A., VanWormerb J.J., DeSouzac C., Ellerbecka E.F., Kimminaud K.S., Greinerd A., Gajewskie B., Huangf T., Perrig M.G., Fazzinoa T.L., Christifanoa D., Eilandc L., Drincicc A. Protocol for the Rural Engagement in Primary Care for Optimizing Weight Reduction (RE-POWER) Trial: Comparing three obesity treatment models in rural primary care. Contemporary Clinical Trials, 2016; 47, 304-314.

Amichaud R., Donatini G., Barussaud M.L., Charalambous C., Ingrand I., Faure J.P. Health-related quality of life after laparoscopic sleeve gastrectomy. Minerva Chirurgica, 2016 Feb 4. [Epub ahead of print]

Rossmeissl A., Lenk S., Hanssen H., Donath L., Schmidt-Trucksäss A., Schäfer J. ZumBeat: Evaluation of a Zumba Dance Intervention in Postmenopausal Overweight Women. Sports, 2016; 4(1), 5; doi:10.3390/sports4010005.

Ding S.A., Simonson D.C., Wewalka M., et al. Adjustable Gastric Band Surgery or Medical Management in Patients With Type 2 Diabetes: A Randomized Clinical Trial. The Journal of Clinical Endocrinology and Metabolism, 2015; 100(7):2546-2556.

Ponce J., Woodman G., Swain J., Wilson E., English W., Ikramuddin S., Bour E., Edmundowicz S., Snyder B., Soto F., Sullivan S., Holcomb R., Lehmann J. for the REDUCE Pivotal Trial Investigators. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surgery for Obesity and Related Diseases, 2015; 11: 874-881.

Camolas A., Ferreira A., Mannucci E., Mascarenhas M.,Carvalho M., Moreira P., do Carmo I., Santos O. Assessing quality of life in severe obesity: development and psychometric properties of the ORWELL-R. Eating and Weight Disorders, 2015; DOI 10.1007/s40519-015-0222-z.

Kolotkin R.L., Chen S., Klassen P., Gilder K., Greenway F. Patient-Reported Quality of Life in a Randomized, Placebo-Controlled Trial of Naltrexone/Bupropion for Obesity. Clinical Obesity, 2015; 5(5): 237-44.

Dixon J.B., Eaton L.L., Vincen V., Michaelson R. LAP-BAND for BMI 30-40: 5-year health outcomes from the multicenter pivotal study. International Journal of Obesity, 2015, Aug 18; doi: 10.1038/ijo.2015.156.

Hain B., Langer L., Hünnemeyer K., Rudofsky G., Zech U., Wild B. Translation and Validation of the German Version of the Weight Self-Stigma Questionnaire (WSSQ). Obesity Surgery, 2015; 25:750-3.

Yancy W.S., Mayer S.B., Coffman C.J., Smith V.A., Kolotkin R.L., Geiselman P.J., McVay M., Oddone E.Z., Voils C.I. Effect of Allowing Choice of Diet on Weight Loss. A Randomized Trial. Annals of Internal Medicine, 2015; 162(12):805-814.

Choo J., Turk M.T., Jae S.Y., Choo I.H. Factors Associated with Health-Related Quality of Life Among Overweight and Obese Korean Women. Women & Health, 2015; 55(2), 152-166.

Andersen J. R., Aasprang A., Karlsen T-I, Natvig G.K., Vage V., Kolotkin R.L. Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies. Surgery for Obesity and Related Diseases, 2015; 11(2): 466-473.

Wee C.C., Davis R.B., Chiodi S., Huskey K.W., Hamel M.B. Sex, Race, and the Adverse Effects of Social Stigma vs. Other Quality of Life Factors Among Primary Care Patients with Moderate to Severe Obesity. Journal of General Internal Medicine, 2015; 30(2): 229-35.

Halperin F., Ding S.A., Simonson D.C., Panosian J., Goebel-Fabbri A., Wewalka M., Hamdy O., Abrahamson M., Clancy K., Foster K., Lautz D., Vernon A., Goldfine A.B. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surgery, 2014 Jul; 149(7):716-26.

Rogers C.A., Welbourn R., Byrne J., Donovan J..L, Reeves B.C., Wordsworth S., Andrews R., Thompson J.L., Roderick P., Mahon D., Noble H., Kelly J., Mazza G., Pike K., Paramasivan S., Blencowe N., Perkins M., Porter T., Blazeby J.M. The By-Band study: gastric bypass or adjustable gastric band surgery to treat morbid obesity: study protocol for a multi-centre randomised controlled trial with an internal pilot phase. Trials, 2014 Feb 11; 15:53. doi: 10.1186/1745-6215-15-53.

Flølo T.N., Andersen J.R., Nielsen H.J., Natvig G.K. Translation, adaptation, validation and performance of the American Weight Efficacy Lifestyle Questionnaire Short Form (WEL-SF) to a Norwegian version: a cross-sectional study. PeerJ, 2014; 2:e565; DOI 10.7717/peerj.565.

Pfeil M., Crozier K., Pulford A., Ferguson Y., Mahon D., Lewis M. Living with a Gastric Band: A Qualitative Study. Healthcare, 2014; 2(1), 47-59.

Araujo, Marília Caixeta De, Dias, João Marcos Domingues, Vasconcelos, Karina Simone de Souza, Medeiros, Adriana Pedrita Pessoa, Santos, Carla Moura, & Dias, Rosângela Correa. Impacto de las condiciones clínicas y funcionales en la cualidad de vida de ancianas con obesidad (Impact of clinical and functional conditions on quality of life in old women with obesity). Fisioterapia e Pesquisa, 2014; 21(4), 372-377.

Traina S., Guthrie R., Slee A. The impact of weight loss on weight-related quality of life and health satisfaction: results from a trial comparing canagliflozin with sitagliptin in triple therapy among people with type 2 diabetes. Postgraduate Medicine, 2014 May; 126(3): 7-15.

Jagielski A.C., Brown A., Hosseini-Araghi M., Thomas G.N., Taheri S. The Association between Adiposity, Mental Well-Being, and Quality of Life in Extreme Obesity. PLoS ONE. 2014; 9(3):e92859.

Berman D. Clinical practice guidelines for the support of bariatric surgery patients: the impact of the 2013 update on the role of psychology. Bariatric Times, 2014; 10 (12), 21-23.

de Zwaan M., Georgiadou E., Stroh C.E., Teufel M., Köhler H., Tengler M., Müller A. Body image and quality of life in patients with and without body contouring surgery following bariatric surgery: a comparison of pre- and post-surgery groups. Frontiers in Psychology, 2014 Nov 18; 5:1310. doi: 10.3389/fpsyg.2014.01310. eCollection 2014.

McVay M.A., Voils C.I., Coffman C.J., Geiselman P.J., Kolotkin R.L., Mayer S.B., Smith V.A., Gaillard L., Turner M., Yancy W.S. Factors associated with choice of a low-fat or low-carbohydrate diet during a behavioral weight loss intervention. Appetite, 2014; 83:117-124.

Marinos G., Eliades C., Raman Muthusamy V., Greenway F. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surgery for Obesity and Related Diseases, 2014; 929-934.

Saboor Aftab S.A., Halder L., Piya M.K., Reddy N., Fraser I., Menon V., Bridgwater S., Kendrick D., Kumar S., Barber T.M. Predictors of weight loss at 1 year after laparoscopic adjustable gastric banding and the role of presurgical quality of life. Obesity Surgery, 2014 Jun; 24(6): 885-90.

Strain G.W., Kolotkin R.L., Dakin G., Gagner M., Inabnet W., Saif T., Christos P., Crosby R.D., Pomp A. The effects of weight loss after bariatric surgery on health-related quality of life and depression. Nutrition and Diabetes, 2014; 4, e132; doi:10.1038/nutd.2014.29.

Miras A., Al-Najim W., Jackson S., et al. Psychological characteristics, eating behavior, and quality of life assessment of obese patients undergoing weight loss interventions. Scandinavian Journal of Surgery, 2014.

Napoli N., Shah K., Waters D.L., Sinacore D.R., Qualls C., Villareal D.T. Effect of weight loss, exercise, or both on cognition and quality of life in obese older adults. American Journal of Clinical Nutrition, 2014; 100(1): 189-198.

Sarwer D.B., Spitzer J.C., Wadden T.A., Mitchell J.E., Lancaster K., Courcoulas A., Gourash W., Rosen R.C., Christian N.J. Changes in sexual functioning and sex hormone levels in women following bariatric surgery. JAMA Surgery, 2014 Jan 1; 149(1): 26-33.

Araghi M.H., Jagielski A., Neira I., Brown A., Higgs S., Thomas G.N., Taheri S. The complex associations among sleep quality, anxiety-depression, and quality of life in patients with extreme obesity. Sleep, 2013; 36(12): 1859-1865.

Reaney M., Mathieu C., Ostenson C.G., Matthaei S., Krarup T., Kiljański J., Salaun-Martin C., Sapin H., Theodorakis M.I., Guerci B. Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study. Health and Quality of Life Outcomes, 2013 Dec 26; 11: 217.

Fuller N.R., Pearson S., Lau N.S., Wlodarczyk J., Halstead M.B., Tee H.P., Chettiar R. and Kaffes A.J. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study. Obesity, 2013; 21: 1561-1570.

Alert M.D., Rastegar S., Foret M., Slipp L., Jacquart J., Macklin E., Baim M., Fricchione G., Benson H., Denninger J. and Yeung A. The effectiveness of a comprehensive mind body weight loss intervention for overweight and obese adults: A pilot study. Complementary Therapies in Medicine, 2013; 21: 286-293.

Michaelson R., Murphy D.K., Gross T.M., Whitcup S.M. LAP-BAND® for Lower BMI: 2-Year Results from the Multicenter Pivotal Study. Obesity, 2013; 21: 1148-1158.

Apovian C.M., Aronne L., Rubino D., et al. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring), 2013; 21: 935-43.

Belle S.H., Berk P.D., Chapman W.H., Christian N.J., Courcoulas A.P., Dakin G.F., Flum D.R., Horlick M., King W.C., McCloskey C.A., Mitchell J.E., Patterson E.J., Pender J.R., Steffen K.J., Thirlby R.C., Wolfe B.M., Yanovski S.Z.. LABS Consortium. Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Surgery for Obesity and Related Disorders, 2013 Nov-Dec; 9(6): 926-35.

Sarwer D.B., Moore R.H., Diewald L.K., Chittams J., Berkowitz R.I., Vetter M., Volger S., Wadden T.A. The impact of a primary care-based weight loss intervention on the quality of life. International Journal of Obesity, 2013; 37: S25-S30.

Wee C.C., Davis R.B., Huskey K.W., Jones D.B., Hamel M.B. Quality of life among obese patients seeking weight loss surgery: the importance of obesity-related social stigma and functional status. Journal of General Internal Medicine, 2013; 28(2): 231-238.

Oh S.H., Song H.J., Kwon J.W., Park D.J., Lee Y.J., Chun H., Kim S., Shim K.W. The improvement of quality of life in patients treated with bariatric surgery in Korea. Journal of the Korean Surgical Society, 2013; 84(3): 131-139.

Yancy W.S., Coffman C.J., Geiselman P.J., Kolotkin R.L., Almirall D., Oddone E.Z., Mayer S.B., Gaillard L.A., Turner M., Smith V.A., Voils C.I. Considering Patient Diet Preference to Optimize Weight Loss: Design Considerations of a Randomized Trial Investigating the Impact of Choice. Contemporary Clinical Trials, 35 (2013); 106-116.

Caixas A., Lecube A., Morales M.J., Calanas A., Moreiro J., Cordido F., Diaz M.J., Masmiquel L., Moreno B., Vidal J., Goday A., Arrizabalaga J.J., Garcia-Luna P.P., Iglesias P., Burguera B., Rubio M.A., Monereo S. (Group for the Study of Obesity of the Spanish Endocrinology and Nutrition Society (SEEN)), Crosby R.D., Kolotkin R.L. Weight-related quality of life in Spanish obese subjects suitable for bariatric surgery is lower than in their North American counterparts. A case-control study. Obesity Surgery, 2013; 23, 509-514.

O'Neil P.M., Smith S.R., Weissman N.J., et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012; 20:1426-36.

Allison D.B., Gadde K.M., Garvey W.T., et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012; 20:330-42.

Wouters E.J.M., Geenen R., Vingerhoets J.J.M. Lijdensdruk en kwaliteit van leven voorspellen uitval bij fysieke trainingsprogramma's voor volwassenen met obesitas. Psychologie & Gezondheid, 2012; 37(5): 267-275.

Davies M., Speight J. Patient-reported outcomes in trials of incretin-based therapies in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, 2012; 14, 882-892.

Awad A.G., Voruganti L.N. Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics, 2012 Mar; 30(3): 183-95.

Vieira P.N., Palmeira A.L., Mata J., Kolotkin R.L., Silva M.N., Sardinha L.B., Teixeira P.J. Are standard body mass index obesity cut-offs relevant for diminished quality of life and psychological well-being in women? Obesity Facts, 2012; 5(6): 795-805.

Vieira P.N., Silva M.N., Mata J., Coutinho S.R., Santos T.C., Sardinha L.B., Teixeira P.J. Correlates of health-related quality of life, psychological well-being, and eating self-regulation after successful weight loss maintenance. Journal of Behavioral Medicine, 2012; DOI:10.1007/s10865-012-9454-9.

Russell-Jones D. et al. Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4). Diabetes Care, 2012; 35: 252-258.

Kolotkin R.L., Zunker C., Østbye T. Sexual Functioning and Obesity: A Review. Obesity, 2012; 20, 2325-2333.

Muller-Pinget S., Carrard I., Ybarra J., Golay A. Dance therapy improves self-body image among obese patients. Patient Education and Counseling, 2012; 89: 525-8

Fuller N.R., Colagiuri S., Schofield D., et al. A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care-an international randomised controlled trial. International Journal of Obesity (London), 2012.

Kolotkin R.L., Davidson L.E., Crosby R.D., Hunt S.C., Adams T.D. Six-year changes in health-related quality of life in gastric bypass patients versus obese comparison groups. Surgery for Obesity and Related Diseases: official journal of the American Society for Bariatric Surgery, 2012; 8: 625-33.

Andres A., Saldana C., Mesa J., Lecube A. Psychometric Evaluation of the IWQOL-Lite (Spanish Version) When Applied to a Sample of Obese Patients Awaiting Bariatric Surgery. Obesity Surgery, 2012; 22: 802-9.

Cox T.L., Ard J.D., Beasley T.M., Fernandez J.R., Howard V.J., Kolotkin R.L., Crosby R.D., Affuso O. Examining the association between body mass index and weight related quality of life in black and white women. Applied Research in Quality of Life, 2012; 7, 309-322.

Beechy L., Galpern J., Petrone A., Das S.K. Assessment tools in obesity - Psychological measures, diet, activity, and body composition. Physiology and Behavior, 2012.

Vasiljevic N., Ralevic S., Kolotkin R.L., Marinkovic J., Jorga J. The relationship between weight loss and health-related quality of life in a Serbian Population. European Eating Disorders Review, 2012; 20, 162-168.

Strain G.W., Saif T., Gagner M., Rossidis M., Dakin G., Pomp A. Cross-sectional review of effects of laparoscopic sleeve gastrectomy at 1, 3, and 5 years. Surgery for Obesity and Related Diseases, 2011; 7 (6), 714-719.

Tayyem R., Ali A., Atkinson J., Martin C.R. Analysis of health-related quality-of-life instruments measuring the impact of bariatric surgery: systematic review of the instruments used and their content validity. The Patient. 2011; 4:73-87.

Gadde K.M., Allison D.B., Ryan D.H., et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011; 377:1341-52.

Fidler M.C., Sanchez M., Raether B., et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. Journal of Clinical Endocrinology and Metabolism, 2011; 96:3067-77.

Makowski C.T., K.M. Gwinn, et al. (2011). Naltrexone/bupropion: an investigational combination for weight loss and maintenance. Obesity Facts, 2011; 4(6): 489-494.

Wadden T.A., Foreyt J.P., Foster G.D., et al. Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial. Obesity, 2011; 19: 110-120.

Shah M., Snell P.G., Rao S., Adams-Huet B., Quittner C., Livingston E.H., Garg A. High-volume exercise program in obese bariatric surgery patients: a randomized, controlled trial. Obesity (Silver Spring), 2011 Sep; 19(9): 1826-34.

Kraschnewski J.L., Stuckey H.L., Rovniak L.S. et al. Efficacy of a weight-loss website based on positive deviance: a randomized trial. American Journal of Preventive Medicine, 2011; 41: 610-614.

Bergenstal R.M., Garrison L.P., Miller L.A., et al. Exenatide BID Observational Study (ExOS): results for primary and secondary endpoints of a prospective research study to evaluate the clinical effectiveness of exenatide BID use in patients with type 2 diabetes in a real-world setting. Current Medical Research and Opinion, 2011; 27: 2335-42.

Boye K.S., Matza L.S., Walter K.N., Van Brunt K., Palsgrove A.C., Tynan A. Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. European Journal of Health Economics, 2011 Jun; 12: 219-30.

Cox T.L., Ard J.D., Beasley T.M., Fernandez J.R., Howard V.J., Affuso O. Body Image as a Mediator of the Relationship Between Body Mass Index and Weight-Related Quality of Life in Black Women. Journal of Women's Health, 2011; 20:1573-1578.

Sirtori A, Brunani A, Liuzzi A, et al. Quality of life, disability, and body mass index are related in obese patients. International Journal of Rehabilitation Research, 2011; 34:270-2.

Hammoud A., Walker J.M., Cloward T., Hunt S.C., Kolotkin R.L., Adams T.D., Meikle A.W. Sleep apnea, reproductive hormones and sexual quality of life in severely obese men. Obesity (Silver Spring), 2011; 19, 1118-23.

Fezzi M., Kolotkin R.L., Nedelcu M., Jaussent A., Schaub R., Chauvet M.A., Cassafieres C., Lefebvre P., Renard E., Bringer J., Fabre J.M., Nocca D. Improvement in Quality of Life After Laparoscopic Sleeve Gastrectomy. Obesity Surgery, 2011; 21, 1161-7.

Therrien F., Marceau P., Turgeon N., Biron S., Richard D., Lacasse Y. The Laval Questionnaire: A new instrument to measure quality of life in morbid obesity. Health and Quality of Life Outcomes, 2011; 9:66 doi:10.1186/1477-7525-9-66.

Tessier A., Mayo N.E., Cieza A. Content identification of the IWQOL-Lite with the International Classification of Functioning, Disability and Health. Quality of Life Research, 2011; 20:467-77.

Mueller A., Holzapfel C., Hauner H., Crosby R D., Engel S.G., Muhlhans B., Kolotkin R.L., Horbach T., de Zwaan M. Psychometric evaluation of the German version of the Impact of Weight on Quality of Life (IWQOL-Lite) questionnaire. Experimental and Clinical Endocrinology & Diabetes, 2011; 119, 69-74.

Kolotkin R.L., LaMonte M.J., Litwin S., Gress R.E., Yanowitz F.G., Hunt S.C. Crosby R.D., Adams T.D. Cardiorespiratory fitness and health-related quality of life in bariatric surgery patients. Obesity Surgery, 2011; 21, 457-464.

Best J.H., Rubin R.R., Peyrot M., et al. Weight-Related Quality of Life, Health Utility, Psychological Well-Being, and Satisfaction With Exenatide Once Weekly Compared With Sitagliptin or Pioglitazone After 26 Weeks of Treatment. Diabetes Care, 2011; 34:314-9.

Smith S.R., Weissman N.J., Anderson C.M., et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. New England Journal of Medicine. 2010; 363:245-56.

Cox T., Zunker C., Wingo B., Thomas D-M, Ard J. Body Image and Quality of Life in a Group of African American Women. Social Indicators Research. 2010; 99:531-40.

Diamant M. et al. Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): An open-label randomized trial. Lancet, 2010; 375: 2234-43.

Wouters E.M., Van Nunen A.M.A., Geenen R., Kolotkin R.L., Vingerhoets J.J.M. Effects of aquajogging in obese adults: a pilot study. Journal of Obesity, 2010. Published online 2009, August 20. doi: 10.1155/2010/231074.

Strain G.W., Faulconbridge L., Crosby R.D., Kolotkin R.L., Heacock L., Gagner M., Dakin G., Pomp A. Health Related Quality of Life (HRQOL) Does Not Vary Among Patients Seeking Different Surgical Procedures to Assist with Weight Loss. Surgery for Obesity and Related Diseases, 2010; 6, 521-525.

Sarwer D.B., Wadden T.A., Moore R.H., Eisenberg M.H., Raper S.E., Williams N.N. Changes in quality of life and body image after gastric bypass surgery. Surgery for Obesity and Related Diseases, 2010; 6:608-14.

Brett Hauber A., Mohamed A., Reed Johnson F., Oyelowo O., Curtis B., Coon C. Estimating importance weights for the IWQOL-Lite using conjoint analysis. Quality of Life Research, 2010; 19:701-9.

Hermansen K., Kolotkin R.L., Hammer M., Zdravkovic M., Matthews D. Patient reported outcomes in patients with type 2 diabetes treated with liraglutide, or glimepiride, both as add-on to metformin. Primary Care Diabetes, 2010; 4(2): 113-117.

de A. Mariano M.H., Kolotkin R.L., Petribe K., de N. L. Ferreira M., Dutra R.F., Barros M.V.G., Almeida. N.C., de L. Filho L.E., Rabelo P.J., Monteiro V., da Silva B.F. Psychometric evaluation of a Brazilian version of the Impact of Weight on Quality of Life (IWQOL-Lite) instrument. European Eating Disorders Review, 2010; 18(1), 58-66.

Greenway F.L., Fujioka K., Plodkowski R.A., et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 2010; 376:595-605.

Wadden T.A., Foreyt J.P., Foster G.D., et al. Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial. Obesity (Silver Spring), 2010.

Pells J.J., Stout A.L., Musante G.J. Expanding Stepped-Care for Obesity: Overview and Evaluation of an Intensive Treatment Program for Adults. Obesity and Weight Management, 2010.

Marie-Pierre Gagnon-Girouard, Catherine Begin, Veronique Provencher, et al., Psychological Impact of a "Health-at-Every-Size" Intervention on Weight-Preoccupied Overweight/Obese Women, Journal of Obesity, vol. 2010, Article ID 928097, 12 pages, 2010. doi:10.1155/2010/928097

Wachholtz A., Binks M., Eisenson H., Kolotkin R., & Suzuki A. Does pain predict interference with daily functioning and weight loss in an obese residential treatment-seeking population? International Journal of Behavioral Medicine, 2010; 17(2): 118-124.

Osei-Assibey G., Kyrou I., Kumar S., Saravanan P., and Matyka K. A. Self-Reported Psychosocial Health in Obese Patients before and after Weight Loss. Journal of Obesity, vol. 2010, Article ID 372463, 6 pages, 2010. doi:10.1155/2010/372463.

Manwaring J.L., Wilfley D.E. The Impact of Weight on Quality of Life (IWQOL) Questionnaire, 2010. In: Handbook of Disease Burdens and Quality of Life Measures, Preedy VR, Watson RR, editors. Springer-Verlag, New York, NY.

Digenio A.G., Mancuso J.P., Gerber R.A., Dvorak R.V. Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. Annals of Internal Medicine. 2009; 150: 255-262.

Rieger E., Dean H.Y., Steinbeck K.S., Caterson I.D., Manson E. The use of motivational enhancement strategies for the maintenance of weight loss among obese individuals: a preliminary investigation. Diabetes Obesity and Metabolism. 2009; 11: 637-40.

Kolotkin R.L., Norquist J., Crosby R.D., Suryawanshi S., Teixeira P.J, Heymsfield S.B, Erondu N., Ngozi Nguyen A.M. One-year health-related quality of life outcomes in weight loss trial participants: Comparison of three measures. Health and Quality of Life Outcomes, 2009; 7, 53.

Peterson C.B., Mitchell J.E., Crow S.J., Crosby R.D., Wonderlich S.A. The efficacy of self-help group treatment and therapist-led group treatment for binge eating disorder. American Journal of Psychiatry, 2009 Dec; 166(12): 1347-54.

Calugi S., Dalle Grave R., Marchesini G. Night eating syndrome in class II-III obesity: metabolic and psychopathological features. International Journal of Obesity (London), 2009 Aug; 33(8): 899-904.

Ghroubi S., Elleuch H., Chikh T., Kaffel N., Abid M., Elleuch M.H. Physical training combined with dietary measures in the treatment of adult obesity. A comparison of two protocols. Annals of Physical and Rehabilitation Medicine, 2009 Jun; 52(5): 394-413.

Zabelina D.L., Erickson A.L., Kolotkin R.L., Crosby R.D. The effect of age on weight-related quality of life in overweight and obese individuals. Obesity (Silver Spring), 2009; 17: 1410-1413.

Best J.H., Boye K.S., Rubin R.R., Cao D., Kim T.H., Peyrot M. Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily. Diabetic Medicine, 2009; 26: 722-728.

Hammoud A., Gibson M., Hunt S.C., Adams T.D., Carrell D.T., Kolotkin R.L., Meikle A.W. Effect of Roux-en-Y gastric bypass surgery on the reproductive hormones and sexual quality of life in obese men. The Journal of Clinical Endocrinology & Metabolism, 2009; 94, 1329-1332.

Forhan M., Vrkljan B., Macdermid J. A systematic review of the quality of psychometric evidence supporting the use of an obesity-specific quality of life measure for use with persons who have class III obesity. Obesity Reviews, 2010.

Kolotkin R.L., Crosby R.D., Gress R.E., Hunt S., Adams T. Two-year changes in health-related quality of life in gastric bypass patients compared to two severely obese groups. Surgery for Obesity and Related Diseases, 2009; 5: 250-256.

Astrup A., Madsbad S., Breum L., Jensen T.J., Kroustrup J.P., Larsen T.M. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet. 2008; 372: 1906-1913.

Curtis B.H., Hayes R., Fehnel S., Zografos L. Assessing the effect of weight and weight loss in obese persons with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity, 2008; 13-23.

Van Gaal L.F., Scheen A.J., Rissanen A.M., Rossner S., Hanotin C., Ziegler O. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study. European Heart Journal, 2008; 29:1761-71.

Bolado-Garcia V.E., Lopez-Alvarenga J.C., Gonzalez-Barranco J., Comuzzie A.G. Reproducibility and sensitivity of the Impact of Weight on Quality of Life questionnaire among obese Mexicans. Gaceta Medica de Mexico, 2008 Sep-Oct; 144(5): 419-25.

Sears D., Fillmore G., Bui M., Rodriguez J. Evaluation of gastric bypass patients 1 year after surgery: changes in quality of life and obesity-related conditions. Obesity Surgury, 2008; 18(12): 1522-5.

Quinn A., Doody C., O'Shea D. The effect of a physical activity education programme on physical activity, fitness, quality of life and attitudes to exercise in obese females. Journal of Science and Medicine in Sport, 2008; 11: 469-72.

Deviere J., Ojeda Valdes G., Cuevas Herrera L., Closset J., Le Moine O., Eisendrath P., Moreno C., Dugardeyn S., Barea M., de la Torre R., Edmundowicz S., Scott S. Safety. Feasibility and weight loss after transoral gastroplasty: First human multicenter study. Surgical Endoscopy, 2008; 22, 589-598.

Loux T.J., Haricharan R.N., Clements R.H., Kolotkin R.L., Bledsoe S.E., Haynes B., Leath T., Harmon C.M. Health-related quality of life before and after bariatric surgery in adolescents, Journal of Pediatric Surgery, 2008; 43: 1275-1279.

Kolotkin R.L., Binks M., Crosby R.D., Østbye T., Mitchell J.E., Hartley G.G. Improvements in sexual quality of life after moderate weight loss. International Journal of Impotence Research. 2008; 20: 487-492.

Kolotkin R.L., Crosby R.D., Gress R.E., Hunt S., Engel S.G., Adams T. Health and health-related quality of life: Differences between men and women who seek gastric bypass surgery. Surgery for Obesity and Related Diseases. 2008; 4:651-659.

Kolotkin R.L., Corey-Lisle P.K., Crosby R.D., Kan H.J., McQuade R. Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care. European Psychiatry. 2008; 23: 561-566.

Kolotkin R.L., Corey-Lisle P.K., Crosby R.D., Swanson J.M., Tuomari V., L'Italien G., Mitchell J.E. Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder. Obesity (Silver Spring), 2008; 16: 749-754.

Sarwer D.B., Fabricatore A.N., Eisenberg M.H., Sywulak L.A., Wadden T.A. Self-reported stigmatization among candidates for bariatric surgery. Obesity (Silver Spring), 2008; 16 Suppl 2: S75-79.

Tham M., Jones S., Chamberlain J., Castle D. The impact of psychotropic weight gain on people with psychosis--patient perspectives and attitudes. Journal of Mental Health. 2007; 16: 771-79.

Annunziato R.A., Lee J.N., Lowe M.R. A comparison of weight-control behaviors in African American and Caucasian women. Ethnicity and Disease. 2007; 17: 262-7.

van Nunen A.M., Wouters E.J., Vingerhoets A.J., Hox J.J., Geenen R. The health-related quality of life of obese persons seeking or not seeking surgical or non-surgical treatment: a meta-analysis. Obesity Surgery, 2007; 17: 1357-66.

Chen E.Y., Bocchieri-Ricciardi L.E., Munoz D., Fischer S., Katterman S., Roehrig M. et al. Depressed mood in class III obesity predicted by weight-related stigma. Obesity Surgery, 2007; 17: 669-71.

Stout A.L., Applegate K.L., Friedman K.E., Grant J.P., Musante G.J. Psychological correlates of obese patients seeking surgical or residential behavioral weight loss treatment. Surgery for Obesity and Related Diseases, 2007; 3: 369-375.

Di Francesco V., Sacco T., Zamboni M., et al. Weight Loss and Quality of Life Improvement in Obese Subjects Treated with Sibutramine: A Double-Blind Randomized Multicenter Study. Annals of Nutrition and Metabolism, 2007; 51: 75-81.

Merideth C.H. Single-center, double-blind, placebo-controlled evaluation of lamotrigine in the treatment of obesity in adults. Journal of Clinical Psychiatry. 2006; 67: 258-262.

Scheen A.J., Finer N., Hollander P., Jensen M.D., Van Gaal L.F. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet, 2006; 368: 1660-72.

Wee C.C., Jones D.B., Davis R.B., Bourland A.C., Hamel M.B. Understanding patients' value of weight loss and expectations for bariatric surgery. Obesity Surgery, 2006; 16: 496-500.

Lustig R.H., Greenway F., Velasquez-Mieyer P., et al. A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion. International Journal of Obesity (London), 2006; 30: 331-341.

Stucki A., Borchers M., Stucki G., Cieza A., Amann E., Ruof J. Content comparison of health status measures for obesity based on the international classification of functioning, disability and health. International Journal of Obesity (London), 2006; 30: 1791-1799.

Duval K., Marceau P., Perusse L., Lacasse Y. An overview of obesity-specific quality of life questionnaires. Obesity Reviews, 2006; 7: 347-360.

Tuthill A., Slawik H., O'Rahilly S., Finer N. Psychiatric co-morbidities in patients attending specialist obesity services in the UK. QJM - Monthly Journal of the Association of Physicians, 2006; 99: 317-325.

Kolotkin R., Crosby R., Corey-Lisle P., Li H., Swanson J. Performance of a weight-related measure of quality of life in a psychiatric sample. Quality of Life Research, 2006; 15: 587-596.

Kolotkin R.L., Binks M., Crosby R.D., Østbye T., Gress R.E., Adams T.D. Obesity and sexual quality of life. Obesity (Silver Spring), 2006; 14: 472-479.

Ziegler O., Filipecki J., Girod I., and Guillemin F. Development and validation of a French obesity-specific quality of life questionnaire: Quality of Life, Obesity and Dietetics (QOLOD) rating scale. Diabetes and Metabolism, 2005; 31(3 Pt 1), 273-283.

Mion F., Napoleon B., Roman S., Malvoisin E., Trepo F., Pujol B., et al. Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients. Obesity Surgery, 2005; 15: 510-6.

Rieger E., Wilfley D.E., Stein R.I., Marino V., Crow S.J. A comparison of quality of life in obese individuals with and without binge eating disorder. International Journal of Eating Disorders, 2005; 37: 234-240.

Engel S.G., Kolotkin R.L, Teixeira P.J., Sardinha L.B., Vieira P.N., Palmeira A.L., Crosby R.D. Psychometric and Cross-National Evaluation of a Portuguese Version of the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) Questionnaire. European Eating Disorders Review, 2005; 13: 133-143.

Adami G.F., Ramberti G., Weiss A., Carlini F., Murelli F., Scopinaro N. Quality of life in obese subjects following biliopancreatic diversion. Behavioral Medicine, 2005; 31: 53-60.

Foster G.D., Phelan S., Wadden T.A., Gill D., Ermold J., Didie E. Promoting more modest weight losses: A pilot study. Obesity Research, 2004; 12: 1271-1277.

Teixeira P.J., Going S.B., Houtkooper L.B., Cussler E.C., Metcalfe L.L., Blew R.M., Sardinha L.B., Lohman T.G. Pretreatment predictors of attrition and successful weight management in women. International Journal of Obesity, 2004; 28: 1124-33.

Teixeira P.J., Palmeira A.L., Branco T.L., Martins S.S., Minderico C.S., Barata J.T., Silva A.M., Sardinha L.B. Who will lose weight? A reexamination of predictors of weight loss in women. International Journal of Behavioral Nutrition and Physical Activity, 2004; 1: 12.

Kolotkin R.L., Westman E.C., Østbye T., Crosby R.D., Binks M., Eisenson H.E. Weight-related Quality of Life in Obese Persons With and Without Binge Eating Disorder. Obesity Research, 2004; 12: 999-1005.

White M.A., O'Neil P. M, Kolotkin R.L, Byrne T.K. Gender, Race, and Obesity-Related Quality of Life at Extreme Levels of Obesity. Obesity Research, 2004; 12: 949-955.

Crosby R.D., Kolotkin R.L., Williams G.R. An integrated method to determine meaningful changes in health-related quality of life. Journal of Clinical Epidemiology, 2004; 57: 1153-60.

Boan J., Kolotkin R.L., Westman E.C., McMahon R.L., Grant J.P. Binge Eating, Quality of Life and Physical Activity Improve After Roux-en-Y Gastric Bypass (RYGB) for Morbid Obesity. Obesity Surgery, 2004; 14: 341-348.

Brazier J.E., Kolotkin R.L., Crosby R.D., Williams G.R. Estimating a Preference-Based Single Index for the Impact of Weight on Quality of Life-Lite Instrument (IWQOL-Lite) from the SF-6D. Value in Health, 2004; 7: 490-498.

Korolija D., Sauerland S., Wood-Dauphinee S., Abbou C.C., Eypasch E., Caballero M.G., Lumsden M.A., Millat B., Monson J.R., Nilsson G., Pointner R., Schwenk W., Shamiyeh A., Szold A., Targarona E., Ure B., Neugebauer E. Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery. Surgical Endoscopy, 2004; 18: 879-897.

Engel S.G., Crosby R.D., Kolotkin R.L., Hartley G.G., Williams G.R., Wonderlich S.A., Mitchell J.E. The Impact of Weight Loss and Regain on Obesity-Specific Quality of Life: Mirror Image or Differential Effect. Obesity Research, 2003; 11: 1207-1213.

Gadde K.M., Franciscy D.M., Wagner H.R., Krishnan R.R. Zonisamide for weight loss in obese adults. Journal of the American Medical Association, 2003; 289: 1820-1825.

Ballantyne G.H. Measuring outcomes following bariatric surgery: weight loss parameters, improvement in co-morbid conditions, change in quality of life and patient satisfaction. Obesity Surgery, 2003; 13: 954-64.

de Zwaan M., Mitchell J.E., Howell L.M., Monson N., Swan-Kremeier L., Crosby R.D., Seim H.C. Characteristics of morbidly obese patients before gastric bypass surgery. Comprehensive Psychiatry, 2003; 44: 428-34.

Kolotkin R.L., Crosby R.D., Williams G.R. Assessing weight-related quality of life in obese persons with type 2 diabetes. Diabetes Research and Clinical Practice, 2003; 61: 125-32.

Kolotkin R.L., Crosby R.D., Pendleton R. et al. Health-related quality of life in patients seeking gastric bypass surgery vs. non-treatment-seeking controls. Obesity Surgery, 2003; 13: 371-7.

Heshka S., Anderson J.W., Atkinson R.L., Greenway F.L., Hill J.O., Phinney S.D., Kolotkin R.L., Miller-Kovach K., and Pi-Sunyer F.X. Weight loss with self-help compared with a structured commercial program. Journal of the American Medical Association, 2003; 289: 1792-1798.

de Zwaan M., Mitchell J.E., Howell L.M., Monson N., Swan-Kremeier L., Roerig J.L., Kolotkin R.L., Crosby R.D. Two measures of health-related quality of life in morbid obesity. Obesity Research, 2002; 10: 1143-51.

Dymek M.P., Le Grange D., Neven K., Alverdy J. Quality of life after gastric bypass surgery: a cross-sectional study. Obesity Research, 2002; 10: 1135-42.

Scholz G.H., Flehmig G., Kahl Y., Gutknecht D., Schmidt U., Tolkmitt S., Kohler-Braunig K., Gabriel C., Dommel S., Krist H., Scholz M. [Proper Weight Loss with Intelligence (MIRA). 2 programs for weight reduction in general practice trial]. MMW Fortschr Med, 2002; 144: 28-32. In German.

Kolotkin R.L., Crosby R.D., Williams G.R. Health-related quality of life varies among obese subgroups. Obesity Research, 2002;10: 748-756.

Fontaine K.R. Health-related quality of life among obese subgroups: Editorial. Obesity Research. 2002;10: 854-855.

Teixeira P.J., Going S.B., Houtkooper L.B., Cussler E.C., Martin C.J., Metcalfe L.L., Finkenthal N.R., Blew R.M., Sardinha L.B., Lohman T.G. Weight loss readiness in middle-aged women: psychosocial predictors of success for behavioral weight reduction. Journal of Behavioral Medicine, 2002; 25: 499-523.

Wadden T.A., Phelan S. Assessment of quality of life in obese individuals. Obesity Research, 2002; 10 Suppl 1: 50S-7S.

Dujovne C.A., Zavoral J.H., Rowe E., Mendel C.M. Silbutramine Study Group. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia. American Heart Journal. 2001; 142: 489-497.

Kolotkin R.L., Crosby R.D., Williams G.R., et al. The relationship between health-related quality of life and weight loss. Obesity Research, 2001; 9: 564-571.

Kolotkin R.L., Meter K., Williams G.R. Quality of life and obesity. Obesity Reviews, 2001; 2: 219-229.

Samsa G.P., Kolotkin R.L., Williams G.R., et al. Effect of moderate weight loss on health-related quality of life: an analysis of combined data from 4 randomized trials of sibutramine vs. placebo. American Journal of Managed Care, 2001; 7: 875-883.

Fujioka K., Seaton T.B., Rowe E., et.al. Weight loss with sibutramine improves glycemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism, 2000; 2: 175-184.